What does DR. DORPMANS - BAELDE, HUISARTSEN do?

DR. DORPMANS - BAELDE, HUISARTSEN is a general practice in Denderleeuw. Private Limited, started on 22 September 2021, 1 establishment.

What is the address of DR. DORPMANS - BAELDE, HUISARTSEN?

The registered office of DR. DORPMANS - BAELDE, HUISARTSEN is located at Drieselken 13, 9473 Denderleeuw.

Is DR. DORPMANS - BAELDE, HUISARTSEN still active?

Yes. According to the CBE (20 September 2026) DR. DORPMANS - BAELDE, HUISARTSEN is active, legal situation “Normale toestand”, started on 22 September 2021.

Is DR. DORPMANS - BAELDE, HUISARTSEN registered on Peppol?

Yes, DR. DORPMANS - BAELDE, HUISARTSEN is registered on the Peppol network with ID 0208:0774411970.

What is the enterprise number of DR. DORPMANS - BAELDE, HUISARTSEN?

The enterprise number of DR. DORPMANS - BAELDE, HUISARTSEN is BE0774411970.

When was DR. DORPMANS - BAELDE, HUISARTSEN founded?

DR. DORPMANS - BAELDE, HUISARTSEN was founded on 22 September 2021.

Who are the directors of DR. DORPMANS - BAELDE, HUISARTSEN?

According to the 2025 annual accounts, the directors of DR. DORPMANS - BAELDE, HUISARTSEN are: Maarten DORPMANS, Elien BAELDE.

Is DR. DORPMANS - BAELDE, HUISARTSEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 September 2021; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. DORPMANS - BAELDE, HUISARTSEN make in 2025?

DR. DORPMANS - BAELDE, HUISARTSEN posted a profit after taxes of € 69,840 in financial year 2025.

What is the revenue of DR. DORPMANS - BAELDE, HUISARTSEN?

As a small company, DR. DORPMANS - BAELDE, HUISARTSEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 90,986.

DR. DORPMANS - BAELDE, HUISARTSEN (Private Limited)

Dossier DR. DORPMANS - BAELDE, HUISARTSEN, printed on 20 September 2026 from databakkes.be/en/0774411970/dr-dorpmans-baelde-huisartsen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. DORPMANS - BAELDE, HUISARTSEN from Denderleeuw, company number BE0774411970, closed financial year 2025 with a result of € 69,840 after tax. For that financial year DR. DORPMANS - BAELDE, HUISARTSEN recorded a gross margin of € 90,986 and equity of € 11,109. Compared with financial year 2024, the result moved from € 71,420 to € 69,840. The company is profitable. The buffer shrank hard: equity is 96 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 27, 2026.

What it is worth Shrank hard

€ 11,109

▼ 96% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 69,840

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 223,960

▲ 13% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 306,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 2,439

▲ 9% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 97

▲ 28% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,520

▲ 106% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 147,262 Gross margin 2022: € 147,262 First fiscal year in the series	€ 83,116 Gross margin 2023: € 83,116 ▼ 44% vs 2022 (€ 147,262) Unfavourable step	€ 93,747 Gross margin 2024: € 93,747 ▲ 13% vs 2023 (€ 83,116) Favourable step	€ 90,986 Gross margin 2025: € 90,986 ▼ 3% vs 2024 (€ 93,747) Unfavourable step	▼ 3%
Profit after taxes	€ 112,015 Profit after taxes 2022: € 112,015 First fiscal year in the series	€ 62,833 Profit after taxes 2023: € 62,833 ▼ 44% vs 2022 (€ 112,015) Unfavourable step	€ 71,420 Profit after taxes 2024: € 71,420 ▲ 14% vs 2023 (€ 62,833) Favourable step	€ 69,840 Profit after taxes 2025: € 69,840 ▼ 2% vs 2024 (€ 71,420) Unfavourable step	▼ 2%
Equity	€ 113,015 Equity 2022: € 113,015 First fiscal year in the series	€ 175,848 Equity 2023: € 175,848 ▲ 56% vs 2022 (€ 113,015) Favourable step	€ 247,269 Equity 2024: € 247,269 ▲ 41% vs 2023 (€ 175,848) Favourable step	€ 11,109 Equity 2025: € 11,109 ▼ 96% vs 2024 (€ 247,269) Unfavourable step	▼ 96%
Total debts	€ 19,530 Total debts 2022: € 19,530 First fiscal year in the series	€ 13,137 Total debts 2023: € 13,137 ▼ 33% vs 2022 (€ 19,530) Favourable step	€ 11,475 Total debts 2024: € 11,475 ▼ 13% vs 2023 (€ 13,137) Favourable step	€ 277,739 Total debts 2025: € 277,739 ▲ € 266,264 vs 2024 (€ 11,475) Unfavourable step	▲ € 266,264
Cash	€ 114,332 Cash 2022: € 114,332 First fiscal year in the series	€ 139,263 Cash 2023: € 139,263 ▲ 22% vs 2022 (€ 114,332) Favourable step	€ 197,725 Cash 2024: € 197,725 ▲ 42% vs 2023 (€ 139,263) Favourable step	€ 223,960 Cash 2025: € 223,960 ▲ 13% vs 2024 (€ 197,725) Favourable step	▲ 13%
Retained profit	€ 112,015 Retained profit 2022: € 112,015 First fiscal year in the series	€ 174,848 Retained profit 2023: € 174,848 ▲ 56% vs 2022 (€ 112,015) Favourable step	€ 246,269 Retained profit 2024: € 246,269 ▲ 41% vs 2023 (€ 174,848) Favourable step	€ 10,109 Retained profit 2025: € 10,109 ▼ 96% vs 2024 (€ 246,269) Unfavourable step	▼ 96%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 306,000 Dividend 2025: € 306,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 132,545 Balance sheet total 2022: € 132,545 First fiscal year in the series	€ 188,986 Balance sheet total 2023: € 188,986 ▲ 43% vs 2022 (€ 132,545) Unchanged	€ 258,744 Balance sheet total 2024: € 258,744 ▲ 37% vs 2023 (€ 188,986) Unchanged	€ 288,847 Balance sheet total 2025: € 288,847 ▲ 12% vs 2024 (€ 258,744) Unchanged	▲ 12%

Key figures of DR. DORPMANS - BAELDE, HUISARTSEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. DORPMANS - BAELDE, HUISARTSEN?

What happened at DR. DORPMANS - BAELDE, HUISARTSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 27, 2026 New annual accounts for financial year 2025: profit of € 69,840 (▼ 2% vs 2024). Source: NBB ↗
Oct 1, 2021 New establishment in Denderleeuw. KBO
Sep 22, 2021 Start of the company according to the CBE. KBO

In short

From € 112,015 profit in 2022 to € 69,840 profit in 2025.

Paid € 91,071 in corporate taxes since 2022.

Best year ever: 2022, with € 112,015 profit.

Paid out € 306,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. DORPMANS - BAELDE, HUISARTSEN? We notify you, reason included.

Follow DR. DORPMANS - BAELDE, HUISARTSEN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Maarten DORPMANS Elien BAELDE

DR. DORPMANS - BAELDE, HUISARTSEN

Behind DR. DORPMANS - BAELDE, HUISARTSEN are Maarten DORPMANS and Elien BAELDE.

See the full network in the app

Directors

According to the 2025 annual accounts

Maarten DORPMANS

Director

Elien BAELDE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Drieselken 13

9473 Denderleeuw

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0774.411.970
VAT number: BE 0774.411.970
Registered office: Drieselken 13, 9473 Denderleeuw
Names & denominations: DR. DORPMANS - BAELDE, HUISARTSEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 September 2021
Peppol: Active · Active since 20 Nov 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗